Halozyme Therapeutics, Inc. (HALO)

71.71 +1.28 (+1.82%) USD  |  NASDAQ  |  Jan 21, 16:00
71.71 0.00 (0.00%) After-Hours: 20:00
More

Halozyme Therapeutics Average Basic Shares Outstanding (Semi Annual)

Average Basic Shares Outstanding (Semi Annual) Chart

View Average Basic Shares Outstanding (Semi Annual) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Basic Shares Outstanding (Semi Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Basic Shares Outstanding (Semi Annual) Range, Past 5 Years

View Average Basic Shares Outstanding (Semi Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Basic Shares Outstanding (Semi Annual) Benchmarks

View Average Basic Shares Outstanding (Semi Annual) Benchmarks
Start Trial
Johnson & Johnson --
Merck & Co., Inc. --
AIM ImmunoTech, Inc. --
Stryker Corp. --
Skye Bioscience, Inc. --